Vitamin K discovery may lead to new treatments for patients at risk from blood clotsFebruary 04, 2004Medical Research Council (MRC) scientists have discovered more about the role that vitamin K plays in the complicated process of how blood clots. Their work, published in Nature, may lead to new treatments for patients at risk from blood clots, including those who have had heart attacks, have coronary artery disease, irregular heart beats, or have had heart valve replacement therapy. The scientists from the MRC's Clinical Sciences Centre at Imperial College, and research institutions in Germany, identified the gene which controls the production of a protein essential for the action of vitamin K, which is necessary for the formation of a clot. Warfarin is currently the best treatment for patients at risk from blood clots. Although scientists know it inhibits the action of vitamin K by targeting the protein, thinning the blood and preventing the formation of life threatening blood clots, they do not understand how this happens. Pinpointing the gene will help scientists understand the link between the protein and vitamin K. The research team studied the genes of warfarin resistant rats and patients, and compared them with the genes of families with an inherited disorder in handling vitamin K which prevents them from forming clots properly. A mutation was found in the same gene in all three groups. This mutation identified the gene which, under normal genetic circumstances, controls the production of the protein responsible for the action of vitamin K. Professor Ted Tuddenham, of the MRC Clinical Sciences Centre, said: "This is an exciting discovery. Patients are treated with warfarin because we knew it prevented the action of vitamin K and therefore the formation of life threatening blood clots. However, we haven't been able to explain how this takes place. "Pinpointing the target of Warfarin will help us find out more about how vitamin K works. And this may lead to the development of more effective blood thinning treatments for all those whose health is at risk from the formation of blood clots." | |||||||||||||||||||||
Science Research Departments
Earth Science Alternative Energy | Anthropology and Archaeology | Earthquakes and Volcanoes | Environment and Nature News | Global Warming | High-Energy and Particle Physics | Ozone Hole | Scientists Slow Light | Tsunami Space Science Astronomy and Space News | Black Holes | Chandra X-Ray Observatory | Extrasolar Planets | Hubble Telescope | International Space Station | Jupiter Galileo Mission | Jupiter Cassini Mission Flyby | Mars Exploration | Mars Odyssey 2001 | Mars Global Surveyor | Mars Polar Lander | Mars Climate Orbiter | Mars Pathfinder | Meteors and Asteroids | Mir Space Station | NEAR Asteroid Probe Mission | Pluto Planet Debate | Search for Extraterrestrial Life | Space Shuttle Program | Space Shuttle Mission: STS-102 | Space Weather Life Science Animal News | Biotechnology and Genetics | Brain Research | Human Cloning | Dinosaur and Fossil Discoveries | Endangered Species | Gene Therapy | Genetically Modified Food | Stem Cell Research | Whales and Whaling |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||